StockData
Rigel Pharmaceuticals Inc logo

Rigel Pharmaceuticals Inc (RIGL) income statement

RIGLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/30
$40.09−1.10 (-2.67%)

Close on Nov 20, 2026Market cap $748.88MP/E 2.5Yield –

See a number that looks wrong?